Advanced company searchLink opens in new window

PACIRA THERAPEUTICS, INC.

Company number FC032939

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Sep 2023 OSDS01 Closure of UK establishment(s) BR018022 and overseas company FC032939 on 7 September 2023
10 Aug 2023 AA Group of companies' accounts made up to 31 December 2022
26 Sep 2022 AA Group of companies' accounts made up to 31 December 2021
08 Jul 2022 OSAP01 Appointment of Lauren Riker as a director on 19 November 2021
01 Jul 2022 OSAP01 Appointment of Stephen Mccairns as a director on 19 November 2021
01 Jul 2022 OSAP01 Appointment of Anthony Molloy as a director on 19 November 2021
01 Jul 2022 OSAP05 Appointment of Stephen Mccairns as a person authorised to represent UK establishment BR018022 on 19 November 2021.
01 Jul 2022 OSTM03 Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 daniel leblanc
01 Jul 2022 OSTM03 Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 david arkowitz
01 Jul 2022 OSTM03 Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 michael clayman
01 Jul 2022 OSTM01 Termination of appointment of Neil Bodick as a director on 19 November 2021
01 Jul 2022 OSTM03 Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 19/11/2021 neil bodick
01 Jul 2022 OSAP05 Appointment of Lauren Riker as a person authorised to represent UK establishment BR018022 on 19 November 2021.
01 Jul 2022 OSTM01 Termination of appointment of Michael Clayman as a director on 19 November 2021
29 Jun 2022 OSAP05 Appointment of Anthony Molloy as a person authorised to represent UK establishment BR018022 on 19 November 2021.
24 Jan 2022 OSCH01 Details changed for a UK establishment - BR018022 Name Change Flexion therapeutics, inc.,10 January 2022
24 Jan 2022 OSNM01 Change of registered name of an overseas company on 20 January 2022 from Flexion therapeutics, inc.
25 Aug 2021 AA Group of companies' accounts made up to 31 December 2020
25 Aug 2021 AA Group of companies' accounts made up to 31 December 2019
26 Jun 2019 AA Group of companies' accounts made up to 31 December 2018
05 Sep 2018 OSAP05 Appointment of David Arkowitz as a person authorised to represent UK establishment BR018022 on 7 May 2018.
31 Jul 2018 OSTM03 Termination of appointment for a UK establishment - Transaction OSTM03- BR018022 Person Authorised to Represent terminated 31/05/2018 frederick w driscoll
31 Jul 2018 OSTM01 Termination of appointment of Frederick W Driscoll as a director on 31 May 2018
24 Jul 2018 AA Group of companies' accounts made up to 31 December 2017
17 May 2017 AA Group of companies' accounts made up to 31 December 2016